Transversus Abdominis Plane Block in the Analgesia of Acute Pancreatitis

Status Not yet recruiting

Clinical Trial Summary

Background Severe abdominal pain is a hallmark of acute pancreatitis (AP). A control pain is often difficult. Transversus Abdominis Plane (TAP) block has been used in pain control in patients with exacerbation of chronic pancreatitis. Objectives To evaluate the effect of Bilateral Blockade of the Abdominal Transverse Muscle Plane (TAP Block) in the analgesic control of patients with acute pancreatitis; compared to standard intravenous analgesia. Methods A randomized controlled trial of parallel groups will be conducted. The Study will have a multicenter development. Study population: Adult patients admitted for episode of AP, with uncontrolled pain (visual analogue scale (VAS) equal to or greater than 5 after the administration of standard analgesia. Randomization Groups: Group A: Patients who will undergo TAP block as analgesic procedure added to standard analgesia. Group B: Patients to whom morphine 2 mg / ev will be administered as analgesic procedure added to standard analgesia. Timing of pain determination (Visual Analogue Scale, VAS): - Before conventional analgesia - Immediately before Randomization - 15 minutes after the administration of the analgesic treatment object of the study. - One hour after the procedure. - Every 8 hours, during the next 4 days or until discharge of the patient. - Whenever the patient needs a dose of supplemental rescue analgesia. Analysis of data All results will be evaluated according to the initial "intention to treat". There will be a blinded assessment of the results after the last patient in the trial has completed the follow-up. The results will be presented as relative risks with their corresponding confidence intervals. P <0.05 will be considered statistically significant. In case of imbalance between the two treatment groups, a multivariate logistic regression is used to correct possible confounding factors.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04037449
Study type	Interventional
Source	Consorci Sanitari Integral
Contact
Status	Not yet recruiting
Phase	N/A
Start date	November 30, 2020
Completion date	November 30, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03609944` - SpHincterotomy for Acute Recurrent Pancreatitis	N/A
Recruiting	`NCT05572788` - Rectal Indomethacin to Prevent Acute Pancreatitis in EUS-FNA of Pancreatic Cysts	N/A
Completed	`NCT03642769` - Lactated Ringer's Versus Normal Saline for Acute Pancreatitis	N/A
Active, not recruiting	`NCT05095831` - EUS Shear Wave for Solid Pancreatic Lesions.
Completed	`NCT04570852` - Acute Pancreatitis Targets (APT) Study	N/A
Recruiting	`NCT03686618` - Secretin for Acute Pancreatitis	Phase 2
Not yet recruiting	`NCT03740685` - Changes in High Sensitive C Reactive Protien With Different Treatment Modalities in Acute Pancreatitis
Completed	`NCT03342716` - Resolution of Organ Injury in Acute Pancreatitis - RESORP
Not yet recruiting	`NCT03342807` - Intravenous Administration of Insulin and Plasma Exchange on Triglyceride Levels in Early Stage of Hypertriglyceridemia-induced Pancreatitis	Phase 4
Terminated	`NCT02959112` - Epinephrine Sprayed on the Papilla Versus Sterile Water Sprayed on the Papilla for Preventing Pancreatitis After Endoscopic Retrograde Cholangiopancreatography	N/A
Recruiting	`NCT05381428` - Prophylaxis of Post-ERCP Acute Pancreatitis	Phase 3
Active, not recruiting	`NCT05955235` - A Long-term Safety Follow-up Study of SCM-AGH in Patients Who Completed SCM-APT2001 Study
Recruiting	`NCT05160506` - Corticosteroids to Treat Pancreatitis	Phase 2
Not yet recruiting	`NCT03082469` - Pancreatitis CytoSorbents (CytoSorb®) Inflammatory Cytokine Removal	Phase 4
Completed	`NCT03672422` - Pediatric Longitudinal Cohort Study of Chronic Pancreatitis
Completed	`NCT00490386` - Helicobacter Pylori and Acute Alcohol Induced Pancreatitis	N/A
Completed	`NCT04188990` - Cost Effectiveness of an Intervention in Hospitalized Patients With Disease-related Malnutrition	N/A
Active, not recruiting	`NCT04743323` - A Case-CrossovEr Study deSign to Inform Tailored Interventions to Prevent Disease Progression in Acute Pancreatitis
Completed	`NCT03829085` - Study of the Diet in Patients With the Diagnostic of Acute Pancreatitis	N/A
Not yet recruiting	`NCT04760847` - Intermittent Fasting for Pancreatitis	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Transversus Abdominis Plane Block in the Analgesia of Acute Pancreatitis — TAPA

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms